Cupid Ltd
Cupid Ltd Q1 FY25 Results & Presentation Highlights: Revenue, Margins & Order Book
Q1 FY25 investor presentation: what the company reported on revenue, margins and projects.
Based on Cupid Ltd's Q1 FY25 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.
The short version
Total Income (₹ in Lakhs): - Q1FY25: 4,402.60 - Q1FY24: 3,519.77 - Growth: +25.1% - Revenue Growth by Product Segment (Q1FY25 vs Q1FY24): - Male and Female contraceptives & Jelly: 89. EBITDA for Q1 FY25: ₹1,056.37 Lakhs, a 265.6% increase from ₹182.12 Lakhs in Q1 FY24.
From Cupid Ltd's Q1 FY25 earnings-call transcript · updated 24 Sept 2026.
Revenue & Sales Performance
- Total Income (₹ in Lakhs):
- Q1FY25: 4,402.60
- Q1FY24: 3,519.77
- Growth: +25.1%
- Revenue Growth by Product Segment (Q1FY25 vs Q1FY24):
- Male and Female contraceptives & Jelly: 89.75% vs 99.55%
- In Vitro Diagnostics (IVDs): 4.06% vs 0.45%
- New Products: 6.19% vs - (new segment)
- Geographic Revenue Split (Q1FY25 vs Q1FY24):
- Domestic: 48% vs 5%
- Export: 52% vs 95%
- No explicit numeric outlook for future revenue or volumes is provided, but the company plans operational expansion including:
- New UAE subsidiary to capture GCC market share
2 more points management made on revenue & sales performance
Profitability & Margins
See what Cupid Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The board has approved the incorporation of a wholly owned subsidiary in UAE to capture market share in the GCC region (Page 3).
- A greenfield plant at Palava is planned; the plant design is ready, and it is expected to be operational by the end of calendar year 2025 (Page 3).
- No specific capex amounts or detailed financial figures related to these expansions or new projects are mentioned in the presentation.
Top-ranked in Personal Products
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Cupid Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points management made on order book & pipeline
Cupid Ltd — Quarterly revenue & net profit
Reported quarterly figures (₹ Cr). Latest: revenue ₹132 Cr, net profit ₹36 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Cupid Ltd's management said in earlier quarters
- Q4 FY24 earnings call analysis →
- Q4 FY25 earnings call analysis →
- Q1 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
- Q4 FY23 earnings call →
- Q3 FY23 earnings call →
- Q2 FY23 earnings call →
- Q1 FY23 earnings call →
- Q4 FY22 earnings call →
Frequently Asked Questions
What were Cupid Ltd Q1 FY25 results?
Total Income (₹ in Lakhs): - Q1FY25: 4,402.60 - Q1FY24: 3,519.77 - Growth: +25.1% - Revenue Growth by Product Segment (Q1FY25 vs Q1FY24): - Male and Female contraceptives & Jelly: 89. EBITDA for Q1 FY25: ₹1,056.37 Lakhs, a 265.6% increase from ₹182.12 Lakhs in Q1 FY24.
What is Cupid Ltd share price analysis?
Cupid Ltd currently shows a neutral. The stock trades at a P/E of 259.3 with a market cap of ₹35,634 Cr. Investors should review the full earnings analysis for detailed insights.
Is Cupid Ltd planning capital expenditure?
The board has approved the incorporation of a wholly owned subsidiary in UAE to capture market share in the GCC region (Page 3).
Keep Cupid Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.